TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 192 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $84,714,000 | +9.7% | 1,085,793 | +33.0% | 0.09% | -1.1% |
| Q1 2021 | $77,205,000 | -17.2% | 816,204 | +6.7% | 0.09% | -23.8% |
| Q4 2020 | $93,248,000 | +38.6% | 765,266 | -0.6% | 0.12% | +16.2% |
| Q3 2020 | $67,284,000 | -8.9% | 770,191 | -32.6% | 0.10% | -17.3% |
| Q2 2020 | $73,838,000 | +196.4% | 1,143,181 | +105.0% | 0.13% | +139.6% |
| Q1 2020 | $24,910,000 | -31.4% | 557,775 | -4.3% | 0.05% | -17.2% |
| Q4 2019 | $36,311,000 | +124.6% | 582,928 | +35.5% | 0.06% | +276.5% |
| Q3 2019 | $16,170,000 | – | 430,074 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |